683 Capital Management »

Aemetis shares owned by 683 Capital Management

Quarter-by-quarter ownership of Aemetis (AMTX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Aemetis

Tip: Access up to 7 years of quarterly data

All positions including Aemetis held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aemetis by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $327k 236k 1.39
2023-12-31 $240k 46k 5.24

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Aemetis

Vanguard Group
Grantham, Mayo, Van Otterloo & Co
Susquehanna International
Geode Capital Management
BlackRock
Marshall Wace
Millennium Management
Citadel Advisors
State Street Corporation
Atlantic Trust
683 Capital Management
Jane Street
Hamilton Capital Partners
D. E. Shaw & Co
Squarepoint Ops

View all funds holding Aemetis